Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02452255 · ClinicalTrials.gov registry record · Phase 2
Fenofibrate and Propranolol in Burn Patients
A Phase 2 study, sponsored by The University of Texas Medical Branch, Galveston.
- Terminated
- Registry status
- Phase 2
- Development phase
- 18
- Enrollment target
NCT02452255 is a Phase 2 study that was terminated before completion, run by The University of Texas Medical Branch, Galveston. The registered enrollment target is 18 participants.
The verdict
NCT02452255, a Phase 2 study, was terminated before completion, sponsored by The University of Texas Medical Branch, Galveston.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 18 participants
- Enrollment target
Study Summary
The proposed study will test the hypothesis that Propranolol, fenofibrate and fenofibrate plus propranolol have therapeutic, physiological, and metabolic effects that will improve clinical outcomes, and the long-term recovery, rehabilitation, and QOL in burned patients.
Interventions
- DRUG Placebo
- DRUG Fenofibrate
- DRUG Propranolol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2015-11 |
| Est. Completion | 2019-07-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02452255
The ClinicalTrials.gov registry entry for NCT02452255 describes a study currently listed as terminated, categorized as Phase 2. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Medical Branch, Galveston, which has 203 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT02452255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02452255 about?
NCT02452255 is a clinical study titled "Fenofibrate and Propranolol in Burn Patients". The proposed study will test the hypothesis that Propranolol, fenofibrate and fenofibrate plus propranolol have therapeutic, physiological, and metabolic effects that will improve clinical outcomes, and the long-term recovery, rehabilitation, and QOL in burned patients.
What is the current status of trial NCT02452255?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 18 participants. The study started on 2015-11. Estimated completion is 2019-07-12.
What interventions are being tested in trial NCT02452255?
The interventions under investigation include: Placebo (DRUG), Fenofibrate (DRUG), Propranolol (DRUG).
Who is sponsoring clinical trial NCT02452255?
This trial is sponsored by The University of Texas Medical Branch, Galveston, which has 203 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.